Shares of Concentra Group (CON) have gained 2.9% over the past four weeks to close the last trading session at $22.03, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $28 indicates a potential upside of 27.1%.The average comprises eight short-term price targets ranging from a low of $25 to a high of $30, with a standard deviation of $1.85. While the lowest estimate indicates an ...

Group 1 - Birkenstock (BIRK) shares have increased by 4.1% over the past four weeks, closing at $54.76, with a mean price target of $68.88 indicating a potential upside of 25.8% [1] - The average of 17 short-term price targets ranges from a low of $57 to a high of $81, with a standard deviation of $7.34, suggesting a relatively high agreement among analysts [2] - Analysts are optimistic about BIRK's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] Group 2 - Over the last 30 days, the Zacks Consensus Estimate for BIRK's current year earnings has increased by 4%, with eight estimates moving higher and one lower [12] - BIRK holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13]

Shares of Monte Rosa Therapeutics (GLUE) have gained 22.5% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $16.14 indicates a potential upside of 222.2%.The mean estimate comprises seven short-term price targets with a standard deviation of $3.98. While the lowest estimate of $10 indicates a 99.6% increase from ...

Shares of Phathom Pharmaceuticals, Inc. (PHAT) have gained 184.1% over the past four weeks to close the last trading session at $8.92, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18.50 indicates a potential upside of 107.4%.The mean estimate comprises eight short-term price targets with a standard deviation of $8.09. While the lowest estimate of $5 indicates a 44% decline f ...

The RealReal (REAL) closed the last trading session at $5.71, gaining 13.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10.10 indicates a 76.9% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $3.09. While the lowest estimate of $7 indicates a 22.6% increase from the current price level, the most optimistic analyst expects ...

Shares of ZipRecruiter, Inc. (ZIP) have gained 43.4% over the past four weeks to close the last trading session at $6.25, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $8 indicates a potential upside of 28%.The mean estimate comprises five short-term price targets with a standard deviation of $1.87. While the lowest estimate of $6 indicates a 4% decline from the current price ...

Shares of Sagimet Biosciences Inc. (SGMT) have gained 70.6% over the past four weeks to close the last trading session at $5.56, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $29.86 indicates a potential upside of 437.1%.The mean estimate comprises seven short-term price targets with a standard deviation of $20.44. While the lowest estimate of $5 indicates a 10.1% decline from ...

HubSpot (HUBS) closed the last trading session at $609.40, gaining 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $763.91 indicates a 25.4% upside potential.The mean estimate comprises 32 short-term price targets with a standard deviation of $66.58. While the lowest estimate of $645 indicates a 5.8% increase from the current price level, the most optimistic analyst expects th ...

Vigil Neuroscience, Inc. (VIGL) closed the last trading session at $7.88, gaining 225.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10 indicates a 26.9% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $5.29. While the lowest estimate of $8 indicates a 1.5% increase from the current price level, the most optimistic analy ...

Shares of QuinStreet (QNST) have gained 8.1% over the past four weeks to close the last trading session at $16.06, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $28.40 indicates a potential upside of 76.8%.The mean estimate comprises five short-term price targets with a standard deviation of $5.90. While the lowest estimate of $19 indicates an 18.3% increase from the current p ...